Taylor C. Harris
CIK 1560168 · Chief Executive Officer · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.63M
Companies
6
Total Filings
45
Lifetime Open-Market Net
$300.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESTA | Director | 1,949 | $92.22 | $179.7K | $0 | 2 | 2026-07-01 |
| PRCT | Director | 137,565 | $17.79 | $2.45M | $250.0K | 7 | 2026-06-10 |
| CUTERA INC (CUTR) Delisted | Chief Executive Officer | 255,744 | $0.10 | $24.8K | $297.3K | 9 | 2025-02-21 |
| MyoKardia, Inc. (MYOK) Delisted | Chief Financial Officer | 8,743 | — | — | -$247.1K | 7 | 2020-04-07 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | SVP & Chief Financial Officer | 0 | — | — | $0 | 3 | 2017-04-28 |
| THORATEC CORP (THOR) Delisted | VP, Chief Financial Officer | 36,742 | — | — | $0 | 16 | 2015-10-08 |
Recent Filings · Page 3 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-19 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-07 | MyoKardia, Inc. (MYOK) Delisted | Sell (S) | −1,683 | -$115.2K | EDGAR |
| 2020-01-03 | MyoKardia, Inc. (MYOK) Delisted | Exer (M) | +4,250 | $0 | EDGAR |
| 2019-04-09 | MyoKardia, Inc. (MYOK) Delisted | Mixed | +2,426 | -$70.6K | EDGAR |
| 2019-02-12 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-05 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-28 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Disp (D) | −62,705 | $0 | EDGAR |
| 2017-03-03 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Tax (F) | −5,307 | -$294.4K | EDGAR |
| 2017-01-20 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Grant (A) | +11,649 | $0 | EDGAR |
| 2015-10-08 | THORATEC CORP (THOR) Delisted | Mixed | −53,599 | -$3.91M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.